Compare the 2026 best Foundayo (orforglipron) providers — Ro, Found, Form Health, Sesame Care, Weight Watchers Med+, and LillyDirect — and see where the PlexusDx Weight Management Protocols fit as a cash-pay, genetics-informed alternative when insurance excludes weight-loss drugs.

DudeMeds advertises compounded semaglutide and tirzepatide from $149+/month with no membership fee, but dose-escalation pricing is not consistently published and review depth is still thin. This review compares DudeMeds against PlexusDx Weight Management Protocols (Microdose GLP-1 at $129/mo flat, Semaglutide Injection $189/mo, Tirzepatide Injection $289/mo) and the optional Precision Peptide Genetic Test for genetic-informed titration.

Honest review of Willow GLP-1 patient reviews, pricing ($299-$549/mo), compounded sourcing, and how PlexusDx Weight Management Protocols compare on cost, formulary, state availability, and the optional Precision Peptide Genetic Test for individualized dose decisions.

TrimRx vs Ro vs PlexusDx in 2026: real annual cost math, compounded vs FDA-approved branded medication, oral pill options, safety oversight, and PlexusDx's optional genetic-baseline test. Includes a four-question decision frame and pricing across PlexusDx Microdose GLP-1, Semaglutide Injection, Tirzepatide Injection, and GLP-Squared.

SkinnyRx vs MEDVi vs PlexusDx compared on cost, formats, oversight, FDA warning letters, and genetic personalization — with PlexusDx Microdose at $129/mo flat as the cheapest cash-pay tier and the Precision Peptide Genetic Test as the only genetic baseline in the three-way comparison.

SHED vs Ro vs PlexusDx for cash-pay GLP-1 weight loss in 2026 — compounded vs FDA-approved branded, real annual cost math, insurance posture, format flexibility, and why genetics inform PlexusDx dose decisions before week one.

Rybelsus (oral semaglutide) is FDA-approved for type 2 diabetes only — not for weight loss. See the real PIONEER weight numbers, the ~$998/month cash price, why insurance rarely covers off-label use, and how PlexusDx Semaglutide Oral ($289/mo+) and the Microdose GLP-1 Protocol ($129/mo) compare on cost and dose flexibility.

Retatrutide (Lilly's investigational triple agonist) and orforglipron (Lilly's oral non-peptide GLP-1) are the two big pipeline stories in 2026 — but neither is FDA-approved yet. Here's the realistic timeline, the Phase 3 data, the announced and unknown pricing, and how PlexusDx's currently-available compounded semaglutide and tirzepatide protocols ($129/mo to $349/mo) compare for someone who needs an option today rather than in 2028.

MEDVi sells two different oral GLP-1 products under one banner: a compounded semaglutide tablet priced after the intake questionnaire and a Wegovy pill route on a separate membership plus medication. We unpack the pricing, the FDA regulatory status, the 72-hour cancellation rule, and where PlexusDx Semaglutide Oral ($289/mo+) and Microdose GLP-1 Protocol ($129/mo flat) fit for cash-pay readers who want a non-injection GLP-1.

Foundayo's $149 headline is a one-month starter price — the real cash-pay year runs $3,338–$3,738 once you escalate. Compare PlexusDx Microdose GLP-1 ($129/mo flat), Semaglutide Oral ($289/mo), and Tirzepatide Oral ($349/mo) on annualized cost.

Foundayo costs $25/month with covered commercial insurance, $50/month on the Medicare GLP-1 Bridge, or $149-$289/mo self-pay through LillyDirect. Most commercial plans don't cover GLP-1s for weight loss in 2026. Compare cash-pay PlexusDx Weight Management Protocols — Microdose at $129/mo flat, Semaglutide Injection $189/mo, Tirzepatide Injection $289/mo — with no membership fee.

Are GLP-1 pills safe? Four are FDA-approved in 2026 (Rybelsus, Ozempic tablets, Wegovy tablet, Foundayo). Patient-specific compounded oral GLP-1s through licensed pharmacies are a separate lawful category. No-prescription drops and gummies aren't legitimate. Here's the safety framework, the boxed-warning context, and where PlexusDx oral protocols fit.